Contact us   |  

The EJP RD has stablished a partnership with the Critical Path Institute

The EJP RD has stablished a partnership with the Critical Path Institute

2022-02-02
The EJP RD has stablished a partnership with the Critical Path Institute

Both organizations will support the creation of an interoperable global data ecosystem for rare diseases to expedite the effective development of new therapies.

The European Joint Programme on Rare Diseases (EJP RD) is proud to announce a collaboration with the Critical Path Institute (C-Path) to advance technologies and methodologies that are fit for regulatory purposes to further global rare disease research and drug development.

Building on their experience, both organizations will support the creation of an interoperable global data ecosystem for rare diseases to expedite the effective development of new therapies. The partnership will benefit patients, regulators, advocacy stakeholders, researchers, and industry.

Further details on this partnership are published on the EJP RD website.